Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026 and Provides Update on Recent Business Progress Life Science Investing
BriaCell Adds NYU Langone Health's Perlmutter Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study Biotech Investing
InMed Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update Pharmaceutical Investing
Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026 Life Science Investing
BriaCell Receives FDA Clearance to Initiate Bria-BRES+ Clinical Study in Breast Cancer Biotech Investing
Aquestive Therapeutics to Report First Quarter 2026 Financial Results and Recent Business Highlights on May 13 and Host Conference Call on May 14 at 8:00 a.m. ET Pharmaceutical Investing
Bristol Myers Squibb to Participate in the Bank of America Securities Healthcare Conference 2026 Life Science Investing
Ocugen, Inc. Announces Pricing of $115 Million of 6.75% Convertible Senior Notes Life Science Investing
AbbVie Highlights New Long-Term Data Advancing Treatment Standards in Inflammatory Bowel Diseases at 2026 Digestive Disease Week® Pharmaceutical Investing
Minerva Neurosciences Provides First Quarter 2026 Financial Results and Business Updates Pharmaceutical Investing
